Sana Biotechnology
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) (NCT06294236) | Sana Biotechnology | 2024-04-29 |
| Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID) (NCT06285422) | Sana Biotechnology | 2024-04-18 |
| Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) (NCT05878184) | Sana Biotechnology | 2023-05-02 |
Track Sana Biotechnology automatically
Every clearance here is in the API, with alerts when new ones post.